Russia plans production of anti-cancer drugs in the Middle East

Russia, together with Arabian investors, are finishing building of a new pharmaceutical factory in Syria, that will specialize on the manufacture of anti-cancer drugs and will be the largest production facility of its kind in the entire Middle East region, according to recent statements of investors and some local analysts in the field of pharmaceutics, reports The Pharma Letter’s local correspondent.

According to factory head Majed al-Msuti, most of its future output will be supplied both to the domestic Syrian market, as well as other Arab countries.

He also said the new plant will be located close to the Syrian capital Damascus and will produce drugs in various forms. According to Mr al-Msuti, that will be primarily drugs in the form of injections, as well as lyophilized vaccines, and tablets.